A comparison of psychosocial and cognitive functioning between depressed and non-depressed patients with cannabis dependence

Journal of Addictive Diseases
Alex M SecoraFrances R Levin

Abstract

Cannabis use and depressive disorders are thought to impair cognitive performance and psychosocial functioning. Both disorders co-occurring may compound the negative effects of these diagnoses. In this study, the authors used the California Computerized Assessment Package as the cognitive performance measure and the Addiction Severity Index as the psychosocial functioning measure to compare individuals who were cannabis dependent and either depressed or not depressed (N= 108: 54 cannabis dependent only, 54 cannabis dependent and depressed or dysthymic). As predicted, cannabis dependent individuals with comorbid depression showed more psychosocial impairment than individuals with cannabis dependence alone. However, contrary to the authors' hypothesis, individuals who were cannabis dependent with comorbid depression showed less cognitive impairment in some California Computerized Assessment Package modules than individuals with cannabis dependence alone. Based on the authors' results, they concluded that the additive effects of cannabis dependency and depression may only be limited to psychosocial domains and may not extend to cognitive functioning.

References

Jun 12, 2014·The American Journal of Drug and Alcohol Abuse·Patrick V RoebkeFrances R Levin
Apr 14, 2015·The American Journal on Addictions·Deirdre A ConroyMichael D Stein
Feb 28, 2019·Cognitive, Affective & Behavioral Neuroscience·Milena RadomanJodi M Gilman

Citations

Jul 1, 1977·The British Journal of Psychiatry : the Journal of Mental Science·J W KnesevichV E Ziegler
Jan 1, 1992·Journal of Substance Abuse Treatment·A T McLellanM Argeriou
Mar 1, 1992·The Journal of Nervous and Mental Disease·D C Hodgins, N el-Guebaly
Jun 1, 1992·The Journal of Applied Psychology·W E Lehman, D D Simpson
May 1, 1992·Journal of Affective Disorders·M P AustinG M Goodwin
Apr 1, 1983·Journal of Consulting and Clinical Psychology·M W O'Hara, L P Rehm
Feb 21, 1996·JAMA : the Journal of the American Medical Association·H G Pope, D Yurgelun-Todd
Mar 1, 1996·The Psychiatric Clinics of North America·D N KleinM B Keller
Jan 1, 1996·Depression·A J GruberM E Brown
Nov 13, 1998·The American Journal of Psychiatry·J WestermeyerS Nugent
Dec 16, 1998·The American Journal of Drug and Alcohol Abuse·S L EamesR D Crosby
Feb 24, 2001·The Australian and New Zealand Journal of Psychiatry·W Hall, Louisa Degenhardt
Mar 21, 2001·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·S F ButlerJ S Cacciola
Sep 21, 2001·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·G B BovassoT G Cook
Nov 1, 2001·Archives of General Psychiatry·H G PopeDeborah Yurgelun-Todd
Nov 15, 2001·Current Psychiatry Reports·H G PopeD Yurgelun-Todd
Dec 1, 2001·The American Journal of Psychiatry·G B Bovasso
Mar 7, 2002·JAMA : the Journal of the American Medical Association·Nadia SolowijMarijuana Treatment Project Research Group
Nov 5, 2002·Journal of Clinical Pharmacology·H G PopeDeborah Yurgelun-Todd
Feb 28, 2003·Journal of Clinical and Experimental Neuropsychology·Jens EgelandKirsten I Stordal
Mar 4, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Richard J PorterAllan H Young
Jun 19, 2003·JAMA : the Journal of the American Medical Association·Ronald C KesslerNational Comorbidity Survey Replication
Jun 24, 2003·Depression and Anxiety·Thomas EllwartEni S Becker
Aug 15, 2003·The Cochrane Database of Systematic Reviews·M Silva de Lima, M Hotopf
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Nov 18, 2003·Addiction·Louisa DegenhardtMichael Lynskey
Dec 16, 2003·Psychological Medicine·A J GruberD Yurgelun-Todd
Mar 31, 2004·Social Psychiatry and Psychiatric Epidemiology·Mikkel Arendt, Povl Munk-Jørgensen
Apr 22, 2004·JAMA : the Journal of the American Medical Association·Edward V Nunes, Frances R Levin
May 6, 2004·JAMA : the Journal of the American Medical Association·Wilson M ComptonFrederick S Stinson
Nov 5, 2004·Comprehensive Psychiatry·David A SolomonMartin B Keller
Mar 1, 2005·Neurotoxicology and Teratology·P A FriedR Gray
Oct 6, 2005·Drug and Alcohol Review·W Hall
Dec 6, 2005·Journal of Affective Disorders·Yvonne Paelecke-HabermannBernd Leplow
Mar 15, 2006·Neurology·Lambros MessinisPanagiotis Papathanasopoulos
Jun 8, 2006·The Australian and New Zealand Journal of Psychiatry·David SchofieldGail Brennan
Sep 14, 2006·Addiction·Valerie S HarderJeremy Arkes
Mar 17, 2007·The American Journal of Drug and Alcohol Abuse·Vito Agosti, Frances R Levin
Mar 30, 2007·Bipolar Disorders·Noel KennedyPatrick McKeon
Apr 4, 2007·The American Journal of Psychiatry·Pearl H Chiu, Patricia J Deldin
Sep 29, 2009·Clinical Psychology Review·Pim CuijpersGerhard Andersson

Related Concepts

Individual Adjustment
Psychometrics
Dysthymic Disorder
Tetrahydrocannabinol
Personality Assessment
Articular System
Reaction Time
Hamilton Rating Scale for Depression
Depressed - Symptom
Impacted Tooth

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.